Heart Rate as a Therapeutic Target in Angina Pectoris

E-ISSN： 1873-4286|19|9|1562-1568

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.9, 2013-03, pp. : 1562-1568

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rate Control with Ivabradine: Angina Pectoris and Beyond

By Parakh Neeraj

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 1, 2011-02 ,pp. : 1-12

Adis International

Access to resources Recommend Favorite

Editorial (Hot Topics: Stable Angina Pectoris: Novel Therapeutic Insights)

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-01 ,pp. : 1549-1549

Bentham Science Publishers

Access to resources Recommend Favorite

Trimetazidine for stable angina pectoris

By Cross H.R.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 5, 2001-05 ,pp. : 857-875

Informa Healthcare

Access to resources Recommend Favorite

Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal

By Thadani Udho

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 17, 2012-12 ,pp. : 2555-2563

Informa Healthcare

Access to resources Recommend Favorite

Nifedipine gastrointestinal therapeutic system (GITS): a guide to its use in hypertension and angina pectoris

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 24, Iss. 5, 2008-05 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite